News for PetMed Express, Inc. (PETS)

Morgan Stanley has revised its price target for PetMed Express (PETS), reducing it from $3.50 to $3.20, while maintaining an Underweight rating on the stock. Th

PetMed Express (PETS) will ring the Nasdaq Opening Bell on April 11, 2025, to celebrate National Pet Day. The event will feature adoptable rescue dogs f

DELRAY BEACH, Fla., April 11, 2025 (GLOBE NEWSWIRE) -- In celebration of National Pet Day, PetMed Express, Inc. ( PETS)””the original consumer pet healthcare

Former pet industry executive with more than 20 years of experience across retail, pet, healthcare, and private equity Third independent director to join the B

**media[590229]**

PetMed Express struggles with falling sales and declining earnings estimates

Pennsylvania-based Lipella Pharmaceuticals Inc. (LIPO) is up over 62 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

Earnings Call Insights: PetMed Express (NASDAQ:PETS) Q3 2025Management ViewSandra Campos, CEO and President, emphasized the company’s focus on strategic...

PetMed Express, Inc. (NASDAQ:PETS) Q3 2025 Earnings Conference Call February 10, 2025 4:30 PM ETCompany ParticipantsReed Anderson - IR, ICRSandra Campos -...

**media[537046]**

PetMed Express stock could surge or sink after this week's quarterly earnings release. Read why I still think PETS stock is a buy.

PetMed Express Inc (PETS) is set to release its Q3 2025 earnings on Feb 10, 2025. The consensus estimate for Q3 2025 revenue is $59.60 million, and the earnings

On December 31, 2024, Vanguard Group Inc executed a strategic transaction involving PetMed Express Inc (PETS). The firm reduced its holdings in PetMed Express b

META_DESC_INVESTMENT_IDEA

Petmed Express sees $124,374 stock purchase by Nina Capital Holdings

DELRAY BEACH, Fla., Jan. 07, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, ( PETS), will participate in the 27th

BIMI Pharmaceuticals (BIMI) experienced a significant drop of 72% in its stock price on the U.S. OTC market. The stock is currently trading at $0.002 per share

BIMI International Medical Inc. (BIMI) saw its stock price surge by 13.33% on the OTC market. The stock is currently priced at $0.009 per share with a trading v

Insider Activity Roundup: Friday's Key Buys and Sells in US Stocks